Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome bd and Chemical Validation of Combination Strategies for Respiratory Inhibitors against Mycobacterium tuberculosis. (2023)
Attributed to:
Development of sustainable academic-industry partnerships: Untapping breakthrough innovation for the treatment and management of infectious diseases
funded by
UKRI Inn.Scholar
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acsinfecdis.2c00283
PubMed Identifier: 36606559
Publication URI: http://europepmc.org/abstract/MED/36606559
Type: Journal Article/Review
Volume: 9
Parent Publication: ACS infectious diseases
Issue: 2
ISSN: 2373-8227